Derlin, T.;                     Bogdanova, N.;                     Ohlendorf, F.;                     Ramachandran, D.;                     Werner, R.A.;                     Ross, T.L.;                     Christiansen, H.;                     Bengel, F.M.;                     Henkenberens, C.    
        Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Cancers 2021, 13, 1516.
    https://doi.org/10.3390/cancers13071516
    AMA Style
    
                                Derlin T,                                 Bogdanova N,                                 Ohlendorf F,                                 Ramachandran D,                                 Werner RA,                                 Ross TL,                                 Christiansen H,                                 Bengel FM,                                 Henkenberens C.        
                Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Cancers. 2021; 13(7):1516.
        https://doi.org/10.3390/cancers13071516
    
    Chicago/Turabian Style
    
                                Derlin, Thorsten,                                 Natalia Bogdanova,                                 Fiona Ohlendorf,                                 Dhanya Ramachandran,                                 Rudolf A. Werner,                                 Tobias L. Ross,                                 Hans Christiansen,                                 Frank M. Bengel,                                 and Christoph Henkenberens.        
                2021. "Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors" Cancers 13, no. 7: 1516.
        https://doi.org/10.3390/cancers13071516
    
    APA Style
    
                                Derlin, T.,                                 Bogdanova, N.,                                 Ohlendorf, F.,                                 Ramachandran, D.,                                 Werner, R. A.,                                 Ross, T. L.,                                 Christiansen, H.,                                 Bengel, F. M.,                                 & Henkenberens, C.        
        
        (2021). Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors. Cancers, 13(7), 1516.
        https://doi.org/10.3390/cancers13071516